Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma
- 1 May 2003
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 185 (5) , 476-480
- https://doi.org/10.1016/s0002-9610(03)00051-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patientsSurgery, 2001
- Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicatorsJournal of Gastrointestinal Surgery, 2000
- Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinomaThe American Journal of Surgery, 2000
- Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Postoperative Adjuvant Chemoradiation Improves SurvivalAnnals of Surgery, 1997
- Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5 fluorouracilInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Adjuvant therapy of resected adenocarcinoma of the pancreasInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancerCancer, 1987
- Periampullary tumors: Which ones should be resected?The American Journal of Surgery, 1985
- Current trends in the diagnosis and treatment of carcinoma of the pancreasThe American Journal of Surgery, 1983
- Total pancreatectomy for ductal adenocarcinoma of the pancreas: Mayo clinic experienceThe American Journal of Surgery, 1981